Seaport Therapeutics is a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines in areas of high unmet patient needs. The Company has a proven strategy of advancing clinically validated mechanisms previously held back by limitations that are overcome with its proprietary GlyphTM technology platform. All the therapeutic candidates in its pipeline of first and best-in-class medicines are based on the Glyph platform, which is uniquely designed to enable oral bioavailability, bypass first-pass metabolism and reduce hepatotoxicity and other side effects. Seaport is led by an experienced team that invented and advanced important neuropsychiatric medicines and are guided by an extensive network of renowned scientists, clinicians and key opinion leaders. For more information, please visit www.seaporttx.com.
Description:
The Senior Manager will get hands-on experience in entrepreneurship, participate in sourcing and due diligence to support Seaport's Innovation team. This includes:
- Ideation and planning for next generation programs
- Integrate commercial and technical factors into well-organized analyses to drive asset creation from Seaport’s technology platform
- Analyze clinical/commercial unmet need in potential indications and perform basic market sizing and competitive analysis
- Undertaking project management & operations of early-stage R&D and new programs
- Interfacing with key opinion leaders as part of sourcing and diligence efforts
- Preparing clear and compelling communication materials, including presentations, for key external stakeholders
Qualifications:
- Creativity, smarts & initiative
- PhD or MD from a top tier institution in a life sciences related field
- 1-2 years of experience in biopharma strategy, biotech venture capital, or life sciences banking
- Strong project management abilities
- Ability to work onsite in Boston, MA 3-5 days per week
- Outstanding interpersonal and communication skills; candidate should feel comfortable interacting with a broad set of stakeholders across the organization
- Highly motivated and results driven individual with a passion for working in a fast-paced and evolving organization
What We Do
Seaport Therapeutics is a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines in areas of high unmet patient needs. We have a proven strategy of advancing clinically validated mechanisms previously held back by limitations we overcome with our proprietary Glyph technology platform. All the therapeutic candidates in our pipeline of first and best-in-class medicines are based on the Glyph platform, which is uniquely designed to enable oral bioavailability, bypass first-pass metabolism and reduce hepatotoxicity and other side effects. We are led by an experienced team that was involved in inventing and developing KarXT and other neuropsychiatric medicines, and are guided by an extensive network of renowned scientists, clinicians and key opinion leaders.
